![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Chem.
Sec. Polymer Chemistry
Volume 13 - 2025 | doi: 10.3389/fchem.2025.1546637
This article is part of the Research Topic Progress in Functional Coatings View all articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Infection is one of the leading causes of failure in titanium-based implant materials during clinical surgeries, often resulting in delayed or non-union of bone healing. Furthermore, the overuse of antibiotics can lead to bacterial resistance. Therefore, developing a novel titanium-based implant material with both antimicrobial and osteogenic properties is of great significance. In this study, chitosan (CS), polydopamine (PDA), and antimicrobial peptides (AMPs) HHC36 were applied to modify the surface of titanium, resulting in the successful preparation of the composite material Ti-PDA-CS/PDA@HHC36 (abbreviated as T-P-C/P@H). CS promotes osteogenesis and cell adhesion, providing an ideal microenvironment for bone repair. PDA enhances the material's biocompatibility and corrosion resistance, offering cell adhesion sites, while both components exhibit pH-responsive characteristics. The HHC36 effectively prevents infection, protecting the bone repair material from bacterial damage. Overall, the synergistic effects of these components in T-P-C/P@H not only confer excellent antimicrobial and osteogenic properties but also improve biocompatibility, offering a new strategy for applying titanium-based implants in clinical settings.
Keywords: Titanium, Chitosan, polydopamine, antimicrobial peptides, Biocompatibility, Antibacterial activity, Osteogenic ability
Received: 17 Dec 2024; Accepted: 05 Feb 2025.
Copyright: © 2025 Peng, Liu, Zhao, Liu, Yu and Yu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yonglin Yu, Department of Pathology, Affiliated hospital of Zunyi Medical University, Zunyi, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.